Total Cost of Revenue
Biogen Total Cost of Revenue increased by 33.4% to $661.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $629.30M to $661.00M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase relative to revenue may indicate rising component costs or manufacturing inefficiencies, whereas a decrease suggests better economies of scale.
Detailed definition
The direct costs attributable to the production of the goods sold and the delivery of services. This typically encompass...
Peer comparison
In the consumer electronics industry, this is often compared against revenue to determine the efficiency of the supply chain.
total_cost_of_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $459.70M | $511.80M | $660.10M | $753.90M | $484.00M | $469.50M | $570.90M | $662.80M | $592.70M | $659.60M | $618.30M | $542.20M | $546.00M | $638.70M | $583.50M | $629.30M | $605.00M | $674.40M | $495.50M | $661.00M |
| QoQ Change | — | +11.3% | +29.0% | +14.2% | -35.8% | -3.0% | +21.6% | +16.1% | -10.6% | +11.3% | -6.3% | -12.3% | +0.7% | +17.0% | -8.6% | +7.8% | -3.9% | +11.5% | -26.5% | +33.4% |
| YoY Change | — | — | — | — | +5.3% | -8.3% | -13.5% | -12.1% | +22.5% | +40.5% | +8.3% | -18.2% | -7.9% | -3.2% | -5.6% | +16.1% | +10.8% | +5.6% | -15.1% | +5.0% |
Product Breakdown
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| SPINRAZA | $54.03M | $54.03M | $54.03M | $54.03M | $53.08M | $53.08M | $53.08M | $53.08M |
| Total | $542.20M | $546.00M | $638.70M | $583.50M | $629.30M | $605.00M | $674.40M | $495.50M |
SPINRAZA, VUMERITY are derived from annual filings.
VUMERITY was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Cost of Revenue at Other Companies
Frequently Asked Questions
- What is Biogen's total cost of revenue?
- Biogen (BIIB) reported total cost of revenue of $661.00M in Q1 2026.
- How has Biogen's total cost of revenue changed year-over-year?
- Biogen's total cost of revenue increased by 5.0% year-over-year, from $629.30M to $661.00M.
- What is the long-term trend for Biogen's total cost of revenue?
- Over 4 years (2021 to 2025), Biogen's total cost of revenue has grown at a 3.3% compound annual growth rate (CAGR), from $2.11B to $2.40B.
- What does total cost of revenue mean?
- The direct cost of making the products or providing the services that a company sells.